https://scholars.lib.ntu.edu.tw/handle/123456789/580125
標題: | Relapse pattern and treatment outcome of curative radiotherapy for primary cutaneous CD30+ anaplastic large-cell lymphoma: A retrospective cohort study | 作者: | Huang B.-S. WAN-YU CHEN CHUN-WEI WANG ANN-LII CHENG Hong J.-H. SUNG-HSIN KUO |
公開日期: | 2016 | 出版社: | Medical Journals/Acta D-V | 卷: | 96 | 期: | 3 | 起(迄)頁: | 394-395 | 來源出版物: | Acta Dermato-Venereologica | 摘要: | Primary cutaneous anaplastic large-cell lymphoma (PCALCL), a unique category of mature T-cell neoplasms, was recognized in the 2008 WHO classification of lymphoid tumour as an indolent primary cutaneous CD30+ lymphoproliferative disorder (1). Radiotherapy (RT), which is frequently used for curative treatment of patients with PCALCL, involves only a few lesions or may be used to palliate the disorder in patients with multiple lesions. However, because of the rarity of PCALCL and the low number of cohort series and case reports investigating the disorder, the outcomes of using curative RT alone for CD30+ PCALCL are underreported, published studies have revealed that rapid recurrence of CD30+ PCALCL occurs within 2-8 months after treatment (2-4). ? 2016 The Authors. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959165497&doi=10.2340%2f00015555-2260&partnerID=40&md5=0fb1d887bf29c8029ea5b20dcb9947dd https://scholars.lib.ntu.edu.tw/handle/123456789/580125 |
ISSN: | 0001-5555 | DOI: | 10.2340/00015555-2260 | SDG/關鍵字: | CD30 antigen; CD30 antigen; tumor marker; adolescent; adult; Article; cancer radiotherapy; cancer recurrence; cancer regression; clinical article; cohort analysis; disease free survival; external beam radiotherapy; female; human; male; overall survival; primary cutaneous anaplastic large cell lymphoma; priority journal; radiation dose fractionation; retrospective study; skin lymphoma; survival rate; treatment outcome; treatment response; immunology; Lymphoma, Primary Cutaneous Anaplastic Large Cell; middle aged; mortality; pathology; radiotherapy dosage; remission; risk factor; Skin Neoplasms; survival analysis; time factor; tumor recurrence; young adult; Adolescent; Adult; Antigens, CD30; Biomarkers, Tumor; Disease-Free Survival; Female; Humans; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Risk Factors; Skin Neoplasms; Survival Analysis; Time Factors; Treatment Outcome; Young Adult |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。